Home > Boards > US Listed > Medical - Drugs > Cocrystal Pharma Inc. (COCP)

I don't understand the motives for the underwritten

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
joe_techi Member Profile
 
Followed By 29
Posts 2,293
Boards Moderated 0
Alias Born 08/31/06
160x600 placeholder
Cocrystal Pharma Presents Data at the 26th International Symposium on Hepatitis C Virus and Related Viruses GlobeNewswire Inc. - 10/8/2019 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/4/2019 8:31:49 AM
Cocrystal Pharma Announces Abstract Accepted for Poster Presentation at 26th International Symposium on Hepatitis C Virus an... GlobeNewswire Inc. - 10/1/2019 8:00:00 AM
Cocrystal Pharma to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 8:05:00 AM
Cocrystal Pharma Presents Positive Preclinical Data for CC-42344 at the Options X for the Control of Influenza Conference GlobeNewswire Inc. - 9/3/2019 8:05:00 AM
Cocrystal Pharma Announces Abstract Accepted for Oral Presentation at the ISIRV: Options X for the Control of Influenza Confe... GlobeNewswire Inc. - 8/21/2019 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 8:31:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 8:32:13 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/23/2019 6:01:32 AM
Cocrystal Pharma Commences Patient Enrollment for Hong Kong Phase 2a Study of CC-31244 for Ultra-Short Treatment of Hepatitis... GlobeNewswire Inc. - 5/20/2019 8:05:00 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 5/15/2019 8:37:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 8:01:26 AM
Cocrystal Pharma Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/10/2019 8:35:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:32:59 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/9/2019 5:15:08 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/30/2019 3:33:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 8:31:43 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 4/25/2019 8:33:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/18/2019 4:27:45 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/15/2019 4:01:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2019 4:31:37 PM
Cocrystal Pharma Reports 2018 Financial Results and Provides Corporate Overview and Business Outlook GlobeNewswire Inc. - 4/1/2019 8:35:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 8:33:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2019 5:15:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2019 5:26:31 PM
joe_techi   Tuesday, 05/01/18 05:59:07 PM
Re: None
Post # of 1223 
I don't understand the motives for the underwritten public offering of the Company’s common stock. Is this a guaranteed sale for the full (expected) $8M? Since the price dropped below $1.90, if someone was pending on the buy, why go for $1.90? If it is a done deal then I guess I can see the reasoning (other than it killed the share price for the rest of us).

It says, "The offering is expected to close on May 3, 2018 subject to customary closing conditions." Does that mean a buyer is identified and the stock is sold already?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist